PRSS8: Potential Drug Target Or Biomarker (G5652)
PRSS8: Potential Drug Target Or Biomarker
Prostasin heavy chain (PRSS8) is a protein that is expressed in various tissues throughout the body, including the heart, lungs, kidneys, and intestines. It is a key component of the cytoskeleton, which is the framework that gives structure to the cell. PRSS8 is involved in the regulation of cell division and growth, as well as the development and maintenance of tissues.
Recent studies have suggested that PRSS8 may have potential as a drug target or biomarker. One of the main reasons for this is the fact that PRSS8 is involved in the development and maintenance of cancer. Many studies have shown that PRSS8 is often expressed in various types of cancer, and that it is involved in the development of cancer cell stem cells. This suggests that PRSS8 may be a useful target for cancer therapies.
Another potential reason why PRSS8 may be a drug target is its role in the regulation of cell division and growth. PRSS8 is involved in the regulation of cell division by allowing the cell to divide and grow in a controlled manner. This is important for the growth and development of tissues, and is also important for the maintenance of the body's immune system.
In addition to its role in cell division and growth, PRSS8 is also involved in the regulation of cell adhesion. This is the process by which cells stick together to form tissues and organs. PRSS8 is involved in this process by helping to stick the cell to the surrounding tissue.
Another potential reason why PRSS8 may be a drug target is its role in the development and maintenance of diseases such as heart disease and diabetes. Many studies have shown that PRSS8 is often expressed in the tissues of people with these conditions, and that it is involved in the development and progression of these diseases. This suggests that PRSS8 may be a useful target for therapies aimed at treating these conditions.
In conclusion, PRSS8 is a protein that is involved in a number of important processes in the body, including cell division and growth, cell adhesion, and the development and maintenance of tissues. As a result, it has potential as a drug target or biomarker. Further research is needed to fully understand the role of PRSS8 in these processes and to determine its potential as a therapeutic agent.
Protein Name: Serine Protease 8
Functions: Possesses a trypsin-like cleavage specificity with a preference for poly-basic substrates. Stimulates epithelial sodium channel (ENaC) activity through activating cleavage of the gamma subunits (SCNN1G)
More Common Targets
PRTFDC1 | PRTG | PRTN3 | PRUNE1 | PRUNE2 | PRX | PRXL2A | PRXL2B | PRXL2C | PRY | PRY2 | PRYP3 | PRYP4 | PSAP | PSAPL1 | PSAT1 | PSAT1P1 | PSAT1P3 | PSCA | PSD | PSD2 | PSD3 | PSD4 | PSEN1 | PSEN2 | PSENEN | PSG1 | PSG10P | PSG11 | PSG2 | PSG3 | PSG4 | PSG5 | PSG6 | PSG7 | PSG8 | PSG9 | PSIP1 | PSKH1 | PSKH2 | PSMA1 | PSMA2 | PSMA3 | PSMA3-AS1 | PSMA3P1 | PSMA4 | PSMA5 | PSMA6 | PSMA7 | PSMA8 | PSMB1 | PSMB10 | PSMB11 | PSMB2 | PSMB3 | PSMB3P2 | PSMB4 | PSMB5 | PSMB6 | PSMB7 | PSMB7P1 | PSMB8 | PSMB8-AS1 | PSMB9 | PSMC1 | PSMC1P2 | PSMC1P4 | PSMC1P9 | PSMC2 | PSMC3 | PSMC3IP | PSMC4 | PSMC5 | PSMC6 | PSMD1 | PSMD10 | PSMD10P1 | PSMD11 | PSMD12 | PSMD13 | PSMD14 | PSMD2 | PSMD3 | PSMD4 | PSMD4P1 | PSMD5 | PSMD6 | PSMD6-AS2 | PSMD7 | PSMD8 | PSMD9 | PSME1 | PSME2 | PSME2P2 | PSME2P3 | PSME3 | PSME3IP1 | PSME4 | PSMF1 | PSMG1